(Q40638305)

22 September 2017

Low-dose mifepristone 200 mg and vaginal misoprostol for abortion (English)

1 reference

22 September 2017

0 references

1 reference

1 reference

E A Schaff

1

1 reference

22 September 2017

S H Eisinger

2

1 reference

22 September 2017

L S Stadalius

3

1 reference

22 September 2017

P Franks

4

1 reference

22 September 2017

B Z Gore

5

1 reference

22 September 2017

S Poppema

6

1 reference

22 September 2017

1 January 1999

1 reference

22 September 2017

1 reference

22 September 2017

59

1 reference

22 September 2017

1-6

1 reference

22 September 2017

1

1 reference

Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Early pregnancy termination with mifepristone and misoprostol in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Dose-response relationships of RU 486.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Absorption kinetics of misoprostol with oral or vaginal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Embryonic ultrasonographic measurements: crown-rump length revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Methotrexate and misoprostol to terminate early pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Single-dose methotrexate: an expanded clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

Methotrexate and misoprostol for early abortion: a multicenter trial. Acceptability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2898%2900150-4

10.1016/S0010-7824(98)00150-4

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference